Bayforest Capital’s Tandem Diabetes Care TNDM Stock Holding History

Bayforest Capital’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$122K	Buy	7,451 +3,659	+96%	+$68.7K	0.18%	194
2026 Q2	$57.2K	Sell	3,792 -3,473	-48%	-$60.6K	0.05%	587
2026 Q1	$139K	Sell	7,265 -20,144	-73%	-$438K	0.16%	241
2025 Q4	$602K	Buy	27,409 +8,114	+42%	+$146K	0.45%	12
2025 Q3	$234K	Buy	19,295 +10,024	+108%	+$136K	0.11%	345
2025 Q2	$173K	Sell	9,271 -17,017	-65%	-$337K	0.08%	407
2025 Q1	$504K	Buy	26,288 +17,436	+197%	+$510K	0.22%	160
2024 Q4	$319K	Buy	+8,852	New	+$299K	0.4%	30

Other funds holding TNDM

GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Paradice Investment Management Denver, Colorado $594M AUM 28.38% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Bayforest Capital's TNDM Position: Q3 2026 in Review

Bayforest Capital increased its Tandem Diabetes Care (TNDM) stake by 96% in Q3 2026, buying an estimated $68.7K and bringing the position to 7,451 shares worth $122K. The position accounts for 0.18% of the portfolio, ranked #194.

Bayforest Capital first reported a position in TNDM in Q4 2024 and has held it in 8 quarters since. The position peaked at $602K in Q4 2025. 163 funds tracked by Wall St. Rank hold TNDM as of Q3 2026.

Bayforest Capital held 7,451 shares of Tandem Diabetes Care worth $122K as of Q3 2026.
Bayforest Capital bought 3,659 Tandem Diabetes Care shares in Q3 2026, an estimated $68.7K.
Tandem Diabetes Care made up 0.18% of Bayforest Capital's portfolio in Q3 2026, its #194 holding.
Bayforest Capital first reported a position in Tandem Diabetes Care in Q4 2024 and has held it in 8 quarters since.
Bayforest Capital's Tandem Diabetes Care position peaked at $602K in Q4 2025.
163 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2026.

Based on Bayforest Capital's 13F filing for Q3 2026, filed 3 Nov 2026.